106 related articles for article (PubMed ID: 7087684)
1. Oral contraceptive and Platelet lipid biosynthesis in female rats: dose-response relationship.
Ciavatti M; Davenas E; Michel G; Renaud S
Lipids; 1982 Feb; 17(2):111-4. PubMed ID: 7087684
[TBL] [Abstract][Full Text] [Related]
2. Modification by oral contraceptives in rat of 14C acetate incorporation into platelet lipids.
Ciavatti M; Renaud S
Horm Metab Res; 1979 Jul; 11(7):441-4. PubMed ID: 478436
[TBL] [Abstract][Full Text] [Related]
3. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of cholesterol and cholesterol precursors in platelets of female rats treated with oral contraceptives.
Ciavatti M; Michel G; Renaud S
Biochim Biophys Acta; 1980 Nov; 620(2):297-307. PubMed ID: 7437455
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of platelet lipids in relation to aggregation in women using oral contraceptives.
Ciavatti M; Davenas E; Blache D; Monnier MA; Renaud S
Contraception; 1982 Jun; 25(6):629-38. PubMed ID: 7116849
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraceptive increases plasma lipid peroxides in female rats. Relationship to platelet aggregation and lipid biosynthesis.
Ciavatti M; Blache D; Renaud S
Arteriosclerosis; 1989; 9(1):84-9. PubMed ID: 2536271
[TBL] [Abstract][Full Text] [Related]
7. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
Odlind V; Weiner E; Victor A; Johansson ED
Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of acetylsalicylic acid on human platelet function in normal volunteers and in women using a combined oral contraceptive regime.
Baele G; Thiery M; Vermeulen A; Barbier F
Thromb Haemost; 1976 Dec; 36(3):623-7. PubMed ID: 1037156
[TBL] [Abstract][Full Text] [Related]
10. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats.
Durand P; Blache D
Atherosclerosis; 1996 Apr; 121(2):205-16. PubMed ID: 9125295
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
12. Enhanced platelet aggregation by oral contraceptives: effect of PG synthetase inhibitors.
Sudhir S; Gupta LC; Singh J; Garg KN
Indian J Physiol Pharmacol; 1982; 26(3):231-4. PubMed ID: 6816736
[TBL] [Abstract][Full Text] [Related]
13. Blood platelet biochemistry in women receiving steroid contraceptives.
Briggs M
Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
[No Abstract] [Full Text] [Related]
14. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and plasma lipids.
Dhillon MK; Sarkar AK; Gupta AN; Devi PK
J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives, lanosterol, and platelet hyperactivity in rat.
Ciavatti M; Dumont E; Benoit C; Renaud S
Science; 1980 Nov; 210(4470):642-4. PubMed ID: 7433990
[TBL] [Abstract][Full Text] [Related]
17. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
18. [Clinical aspects of a new, very low dose combination contraceptive].
Mladenović D; Grcić R; Pestelek B; Kapor M
Fortschr Med; 1978 Apr; 96(13):723-6. PubMed ID: 631715
[TBL] [Abstract][Full Text] [Related]
19. Metabolic studies in women with previous gestational diabetes during contraceptive treatment: effects on serum lipids and high density lipoproteins.
Rådberg T; Gustafson A; Skryten A; Karlsson K
Acta Endocrinol (Copenh); 1982 Sep; 101(1):134-9. PubMed ID: 7124287
[TBL] [Abstract][Full Text] [Related]
20. [Changes in plasma lipids caused by oral contraceptives].
Kaffarnik H
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
